We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVL icon
376
Marvell Technology
MRVL
$170B
$235K ﹤0.01%
3,355
-332
-9% -$23.3K
OPLN
377
Openlane
OPLN
$4.25B
$233K ﹤0.01%
+14,062
New +$241K
MASI
378
DELISTED
Masimo
MASI
$233K ﹤0.01%
+1,848
New +$243K
VECO icon
379
Veeco
VECO
$2.96B
$230K ﹤0.01%
4,918
-7,484
-60% -$296K
OWL icon
380
Blue Owl Capital
OWL
$6.54B
$227K ﹤0.01%
12,811
-28,901
-69% -$530K
VERA icon
381
Vera Therapeutics
VERA
$2.53B
$224K ﹤0.01%
6,191
-4,017
-39% -$159K
NMFC icon
382
New Mountain Finance
NMFC
$649M
$223K ﹤0.01%
+18,190
New +$228K
TDC icon
383
Teradata
TDC
$2.8B
$222K ﹤0.01%
6,432
-2,670
-29% -$93.2K
MBC icon
384
MasterBrand
MBC
$1.12B
$218K ﹤0.01%
14,837
+2,007
+16% +$33.2K
BIIB icon
385
Biogen
BIIB
$29.5B
$216K ﹤0.01%
+931
New +$202K
RIOT icon
386
Riot Platforms
RIOT
$8.31B
$213K ﹤0.01%
+23,332
New +$235K
VC icon
387
Visteon
VC
$2.82B
$213K ﹤0.01%
1,996
-112
-5% -$12.4K
CTRN icon
388
Citi Trends
CTRN
$543M
$208K ﹤0.01%
+9,807
New +$225K
POST icon
389
Post Holdings
POST
$4.14B
$208K ﹤0.01%
+1,997
New +$208K
ALTR
390
DELISTED
Altair Engineering Inc
ALTR
$207K ﹤0.01%
+2,113
New +$186K
CYRX icon
391
CryoPort
CYRX
$764M
$207K ﹤0.01%
+29,982
New +$404K
UHS icon
392
Universal Health Services
UHS
$9.64B
$207K ﹤0.01%
1,119
-1,591
-59% -$282K
MTSI icon
393
MACOM Technology Solutions
MTSI
$20.1B
$207K ﹤0.01%
+1,856
New +$189K
MODV
394
DELISTED
ModivCare
MODV
$206K ﹤0.01%
+7,836
New +$198K
SMAR
395
DELISTED
Smartsheet Inc.
SMAR
$205K ﹤0.01%
+4,640
New +$185K
TALK icon
396
Talkspace
TALK
$874M
$204K ﹤0.01%
+88,712
New +$255K
KIDS icon
397
OrthoPediatrics
KIDS
$509M
$203K ﹤0.01%
+7,072
New +$217K
XMTR icon
398
Xometry
XMTR
$4.75B
$203K ﹤0.01%
+17,543
New +$276K
NWLI
399
DELISTED
National Western Life Group, Inc. Class A
NWLI
$203K ﹤0.01%
+408
New +$200K
TTWO icon
400
Take-Two Interactive
TTWO
$45.3B
$202K ﹤0.01%
+1,301
New +$197K
14 15
16
17 18

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.